Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.
Eligibility criteria
Qualifiers
age >18 years, both sexes;
written informed consent;
affiliation to a social security regime;
a recent diagnosis of COVID19 (6±3 months) proven by PCR or serology (for group 1,2,3)
Disqualifiers
Age <18 years
Inability to express consent of the study
Diseases carrying out a life -expectancy <1 year according to clinical judgment
Pregnancy and breastfeeding
Trial design
Treatments tested in this trial
- carotid-femoral pulse-wave velocity
Treatment groups
360 Participants
are divided into 4 treatment groupsLocations
3CHRU Nancy54500, Nancy France
Hôpital Européen Georges Pompidou - APHP75015, Paris France
CHU Rouen76031, Rouen France
Sponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
The Association for Research into Arterial Structure and Physiology
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Source ClinicalTrials.gov